Stocks like CIE Automotive India, Sanofi Consumer Healthcare, Delta Corp, Mahindra and Mahindra, Grindwell Norton, Keystone ...

Despite successful models in a few parts of India where regulated access to opioids has been implemented safely, there ...

Based on extensive collaboration with veterinarians, industry, food animal producers and other stakeholders, we have developed the List of Needed Veterinary Drugs. As Health Canada cannot compel drug ...

The Union Budget 2025 has waived import duty on 36 life-saving drugs and reduced it for another ... essential medicines — those covered under the National List of Essential Medicines (NLEM ...

It can occur with prescription or nonprescription drugs. It can also range from mild to severe. Substance use disorder, formerly known as “drug abuse,” develops when substance use interferes ...

Budget 2025: The Finance Minister also informed that the government will exempt basic custom duty on 37 more medicines. (Image Credits: FE) Budget 2025: Finance Minister Nirmala Sitharaman on ...

Agencies This update is expected to impact drug makers like Aarti Drugs, Cipla, Abbott India, Ajanta Pharma, Alkem Labs, AstraZeneca, Biocon, Lupin, and Dr. Lal Path Labs. Sitharaman stated that the ...

All eyes were on what gets cheaper and what gets expensive as the Finance Minister announced major customs duty changes on several products from cancer drugs to wet blue leather ... two more types of ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of the budget announcements.

The drug she received — a new kind of analgesic being tested in a clinical trial — eased her discomfort, without the grogginess or nausea of opioids. “I felt very lucid,” says Vairin ...

while Cancer drug Revlimid sales came in stable, though, with stiff competition, FY26 sales pattern is set to differ for Revlimid. While brokerages in unison sang praises on the Q3 positive earnings ...

Pharma major Cipla Ltd on Tuesday posted its highest-ever quarterly revenue and Ebitda margin, as robust sales in India, Europe and emerging markets outweighed weakness in its US business.